Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stomach medicament

A technology of gastric medicine and raw material medicine, applied in the direction of drug combination, digestive system, active ingredients of heterocyclic compounds, etc., to achieve the effect of short taking time, overcoming high price and low production cost

Inactive Publication Date: 2012-04-25
封勇刚
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to overcome the defects of large side effects, high price, long treatment time and easy recurrence of these medicines for the treatment of stomach diseases at present, and provide a kind of Inexpensive, short treatment time, and gastric medicine with obvious therapeutic effect and few side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stomach medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Weigh 1 part of vitamin B1, 1 part of Literin and 1 part of atropine, grind them into powder and mix them evenly. That is, the weight ratio of vitamin B1, ritterine and atropine in this embodiment is 1:1:1. Similarly, as long as the weight ratio of vitamin B1, ritterine and atropine is 1:1:1, any number of parts can be used, such as using 2 parts of vitamin B1, 2 parts of ritterine and 2 parts of atropine, or using 3 parts 3 parts of vitamin B1, 3 parts of Literin and 3 parts of atropine.

[0018] The so-called 1 part of vitamin B1, 1 part of ritterine and 1 part of atropine means that the weights of these original medicinal materials are the same, as in the present embodiment, 10 g of vitamin B1, 10 g of riterine and 10 g of atropine are preferred. to realise.

[0019] In order to prove the effect of the present invention, 10,000 cases of old stomach disease patients and 10,000 cases of duodenogastritis early stage patients were selected to take the medicine in this ...

Embodiment 2

[0022] Weigh 1 part of vitamin B1, 2 parts of riterine and 1 part of atropine, that is, use 10 g of vitamin B1, 20 g of riterine and 10 g of atropine, develop into powder and mix evenly. At this time, the weight ratio of vitamin B1, ritterine and atropine in this embodiment is 1:2:1.

[0023] The present embodiment has screened 10000 cases of chronic gastric disease patients, and 10000 cases of duodenogastritis early stage patients take this medicine. After taking this medicine again for 4 to 7 days, 9752 patients with old stomach disease were cured, and 9861 patients with duodenum gastritis were cured at the initial stage.

[0024] At this time, vitamin B2 was used to replace vitamin B1, and 9,722 patients with old stomach disease were cured, and 9,789 patients with early duodenitis were cured.

Embodiment 3

[0026] Weigh 1 part of vitamin B1, 3 parts of ritterin and 1 part of atropine, that is, use 10 g of vitamin B1, 30 g of ritterin and 10 g of atropine, develop into powder and mix evenly. At this time, the weight ratio of vitamin B1, ritterine and atropine in this embodiment is 1:3:1.

[0027] In this embodiment, 10,000 cases of old stomach disease patients and 10,000 cases of duodenogastritis early stage patients were screened to take the drug. After taking this medicine again for 4 to 7 days, 9684 patients with old stomach disease were cured, and 9753 patients with duodenum gastritis were cured at the initial stage.

[0028] At this time, vitamin B2 was used to replace vitamin B1, and 9652 patients with old stomach disease were cured, and 9674 patients with early duodenitis were cured.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a stomach medicament which is characterized by being prepared from the following medicinal materials in parts by weight: 1-3 parts of vitamin, 1-3 parts of furazolidone and 1-3 parts of atropine, wherein the weight ratio of the vitamin to the furazolidone to the atropine is 1:1:1, and the vitamin is vitamin B1 or B2. The invention has the advantages of simple composition, low cost, obvious curative effect, fast action, no toxicity and no side effects, thereby being suitable for popularization.

Description

technical field [0001] The invention relates to a medicine, in particular to a stomach medicine for treating old stomach disease. Background technique [0002] For a long time, stomach problems have always been a chronic disease that people cannot completely eradicate. With the improvement of living standards, there are more and more medicines for treating these stomach diseases. However, at present, these medicines for treating stomach diseases have very limited drug effects, not only have large side effects, are expensive, but also take a long time for treatment and are prone to relapse. Contents of the invention [0003] The purpose of the present invention is to overcome the defects of large side effects, high price, long treatment time and easy relapse of the current medicines for treating stomach diseases, and provide a medicine that is not only cheap, short treatment time, but also has obvious therapeutic effect and small side effects. stomach medicine. [0004...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/525A61K31/51A61K31/422A61K31/46A61P1/00A61P1/04
Inventor 封勇刚
Owner 封勇刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com